CCL2 and concussion: Niu et al.62 found that elevated serum levels of chemokine ligand 2 (CCL2), also known as macrophage chemotactic protein-1 (MCP-1), assessed at 7 days and 3 months post-injury, independently posed a risk for greater impact of headaches in mTBI patients.